Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycythemia Vera × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Neoplasms 48 Lung Neoplasms 30 Colorectal Neoplasms 28 Carcinoma, Non-Small-Cell Lung 23 Prostatic Neoplasms 19 Melanoma 19 Pancreatic Neoplasms 15 Ovarian Neoplasms 14 Multiple Myeloma 12 Sarcoma 11 Lymphoma 11 Uterine Cervical Neoplasms 10 Neoplasm Metastasis 10 Leukemia, Myeloid, Acute 10 Glioblastoma 10 Colonic Neoplasms 10 Hematologic Neoplasms 9 Neoplastic Cells, Circulating 8 Head and Neck Neoplasms 8 Glioma 8 Lymphoma, Follicular 7 Leukemia 7 Carcinoma, Hepatocellular 7 Myelodysplastic Syndromes 6 Disease 6 Brain Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Papillomavirus Infections 5 Kidney Neoplasms 5

Interventions

fludarabine phosphate 27 Peripheral Blood Stem Cell Transplantation 22 Cyclophosphamide 22 ruxolitinib 21 Busulfan 17 Whole-Body Irradiation 14 Mycophenolic Acid 13 Tacrolimus 12 Cyclosporine 11 Methotrexate 10 Antilymphocyte Serum 10 fludarabine 8 Aspirin 8 Melphalan 7 Hydroxyurea 7 Filgrastim 7 Etoposide 7 Decitabine 7 Cytarabine 6 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6 peginterferon alfa-2a 5 givinostat hydrochloride 5 givinostat 5 Radiotherapy 5 Biopsy 5 Stem Cell Transplantation 4 Prednisone 4 Phlebotomy 4 Methylprednisolone 4 Imatinib Mesylate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003325 2024-09-19

Low-PV

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Phase 2 Completed

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡